Interestingly, the effect of GSK-3 isoform deletion on HFD-induced obesity was completely the opposite: GSK-3α KOs were protected; however, GSK-3β KOs on chronic HFDs gained more weight, thereby losing the protective effect on glucose tolerance. Here, GSK3A is linked to obesity due to melanocortin 4 receptor deficiency.